Every clinic is licensed, listed and advertising what it treats.
For suppliers of medical and dental consumables, instruments and practice equipment. An AI sales agent that identifies practices from public registers, qualifies them by the treatments they advertise, and contacts them under both the ePrivacy rules and the healthcare promotion rules that apply in each country.
How do you find and qualify clinics?
Clinics are among the most enumerable buyers in any industry. They are licensed, listed in professional registers and chamber directories, and they advertise their treatments publicly because patients have to find them. What they list tells you what they consume: a dental practice advertising implantology buys differently from one offering general dentistry only, and a clinic promoting a named technology platform has already invested in it. Practice size, treatment rooms, practitioner count and group ownership complete the picture.
theagency47 · Updated August 2026This vertical has two layers of compliance, not one.
Everywhere else on this site we talk about ePrivacy: which countries permit unsolicited B2B email and which require consent. That applies here too. But in healthcare there is a second layer, and any supplier who does not mention it has not looked.
Most European countries regulate how medical devices and products may be promoted to healthcare professionals. Several restrict specific claims, comparative statements and inducements. The rules differ by country and by product class, and they are enforced by different authorities from the ones enforcing ePrivacy.
How we handle it. No market is activated for your product class until the applicable promotion rules have been scoped and confirmed — and for regulated device classes we would expect that confirmation to come from your own regulatory adviser rather than from us. We build the mechanism that enforces the rules; we do not certify what the rules are. If the review shows the constraints make outreach impractical for your product, we will say so rather than build something you cannot lawfully use.
The same caution applies to who places the call. An automated call is a stricter category than a human one — express prior consent, with no business-to-business exception in Germany — and in a sector where the promotional rules are already tight, an AI-placed cold call to a practice is not a risk worth taking. A person makes the first approach. Once a practice has consented, the voice agent can handle the recurring contact — reorder prompts, new-line notifications, re-qualification — which is where the volume actually is in consumables.
What the system looks at in your trade.
Treatments advertised
The primary signal. What a practice publicly offers determines what it consumes — and, for equipment, what platform it has already committed to.
Specialty and accreditation
Registered specialty, professional body membership and any accreditation the practice publishes. Determines both product relevance and what may lawfully be communicated.
Practice scale
Chairs, treatment rooms, practitioners, opening hours, number of sites. For consumables this is the volume predictor; for equipment it is the budget predictor.
Independent or group
A single practice is one decision. A group is a framework agreement and a central procurement contact — a different approach entirely.
New practices and relocations
A practice opening or moving is equipping from zero, with no incumbent supplier. Visible from registrations, announcements and recruitment.
New service lines
A practice adding a treatment it did not previously offer is buying the consumables and instruments that treatment requires, usually within weeks of announcing it.
Practitioner movement
A new principal or associate brings their own preferences. Purchasing relationships reset when the person who chose them leaves.
Installed platform
Where a practice names its equipment or materials, compatibility and comparison become concrete — within whatever claims are permitted in that market.
Distributor and group mapping
Much of this sector buys through distributors and buying groups. The system maps them so you approach at the level where the decision is actually made.
Consumables are where this pays back.
A practice that adopts a consumable and finds it reliable reorders without re-running the decision. Each account is an annuity rather than a sale, which is what makes systematic prospecting worth industrialising — the first year covers acquisition, and the second year is where the case is made.
Equipment behaves differently: longer cycles, larger values, and a purchase that happens when a practice opens, expands or replaces. The system is good at finding those moments; it cannot create them. If you sell both, we would start on the consumable line.
Questions medical and dental suppliers ask.
How do you find and qualify clinics?
Clinics and practices are among the most enumerable buyers in any industry. They are licensed, listed in professional registers and chamber directories, and they advertise their treatments publicly because patients need to find them. The treatments listed tell you what they consume: a dental practice advertising implantology buys different products from one offering only general dentistry, and a clinic promoting a named technology has already invested in that platform. Practice size, number of chairs or treatment rooms, number of practitioners and group ownership complete the picture.
What are the compliance rules for contacting healthcare professionals?
There are two layers, not one. The first is ePrivacy, which decides whether unsolicited B2B email is lawful at all — Germany, Italy, Austria, Spain and Poland require prior opt-in consent. The second layer is specific to healthcare: most European countries regulate how medical devices and products may be promoted to healthcare professionals, and several restrict or prohibit certain claims, comparisons and inducements. Those rules sit on top of ePrivacy and differ by country and product class. We scope this explicitly before any market is activated, and we would expect the rules for your specific product class to be confirmed by your own regulatory adviser.
Is this suitable for medical device manufacturers?
For consumables, instruments and general practice equipment, yes — those are the clearest cases. For regulated medical devices, particularly higher-risk classes, the promotional rules are more restrictive and vary considerably between countries. We would not activate a market for a regulated device class without your regulatory adviser confirming what may be communicated, to whom, and in what form. If that review shows the constraints make outreach impractical for your product, we will tell you rather than build something you cannot use.
Next: See the full system →
